Distinct responses of conventional and unconventional T cells to Group A Streptococcus in healthy adults (#201)

5:30 PM

Mohammad Ali

Killing Strep A softly – towards standardised reagents for Streptococcus pyogenes immunoassays (#202)

5:30 PM

Kristy I Azzopardi

 Can Group B Streptococcus (GBS) strain diversity in carriage be recovered from low-abundance metagenomic samples? A simulation study (#203)

5:30 PM

Ruchita Balasubramanian

Global Population Biology and Tissue Tropism Correlates for M- and FCT-Region Genes (#204)

5:30 PM

Debra E Bessen

New insights into the regulatory networks that control streptococcal superantigen production (#205)

5:30 PM

Stephan Brouwer

PrsA in group A Streptococcus: implications for pathogenesis and therapeutic targeting (#206)

5:30 PM

Yung-Chi Chang

Regulatory mechanisms of GAC side chain modifications in Group A Streptococcus (#207)

5:30 PM

Lorenzo G De la Parra Soto

Glyburide as an adjunct agent to treat inflammatory changes associated with post-streptococcal cardiac pathology (#208)

5:30 PM

Jasen Elford

Multidrug resistance in group B streptococcus causing urinary tract infection exposes an erythromycin-driven protective effect against oxidative stress (#209)

5:30 PM

Kelvin GK Goh

Characterising cross-reactive properties of the antibody response to Group A Streptococcus (GAS) and in rheumatic heart disease (#210)

5:30 PM

Zichen He

How to utilize a genome-scale metabolic model and iModulon in the research of Streptococcus pyogenes M1 serotype (#211)

5:30 PM

Yujiro Hirose

Differences in glycan binding modulate M1 Streptococcus pyogenes tissue tropism (#212)

5:30 PM

Kristin K Huse

Search and characterization of novel RNA-binding proteins in Streptococcus pyogenes (#213)

5:30 PM

Dmitriy Ignatov

Transcriptomic predictors of delayed mortality in patients with invasive group A streptococcal disease (#214)

5:30 PM

Ville Kailankangas

Serologic responses in patients with invasive group A streptococcal disease and concomitant throat findings (#215)

5:30 PM

Ville Kailankangas

Population genomics of Streptococcus pyogenes in patients admitted at a tertiary hospital in Malawi (2012–2023) (#216)

5:30 PM

Akuzike Kalizang'oma

Pneumococcal-like capsule polysaccharide loci among Streptococcus mitis bloodstream isolates from infective endocarditis cases in the UK and Ireland from 2001-2016 (#217)

5:30 PM

Akuzike Kalizang'oma

Junk or adjunct? The place of protein synthesis inhibitors for treatment of severe invasive Streptococcus pyogenes infections in a time of rising clindamycin resistance (#218)

5:30 PM

Louise Kelly

Immune Responses In Siblings With Acute Rheumatic Fever – A Case Study (#219)

5:30 PM

Natalie Lorenz

Streptococcus pyogenes biofilm phenotypic and genotypic changes in response to host stressors (#220)

5:30 PM

Georgia M McCorkell

Novel Transporters Impacting the Pathophysiology of Group A Streptococcal Infections (#221)

5:30 PM

Kevin S McIver

Profiling inflammatory resolution over 6 months in acute rheumatic fever (#222)

5:30 PM

Francis M Middleton

Deciphering the pan-methylome of group A Streptococcus (#223)

5:30 PM

August Mikucki

The longitudinal characterisation of immune responses in the Rat Autoimmune Valvulitis model enables the assessment of disease severity and the identification of biomarkers for ARF/RHD screening (#224)

5:30 PM

Rukshan Ahamed Mohamed Rafeek

Role of streptococcal inhibitor of complement and streptococcal nephritogenic antigens in the pathogenesis of post-streptococcal glomerulonephritis (#225)

5:30 PM

Mohammad Raguib Munif

Group A Streptococcus modulates AMPK-mTOR signaling via NADase and inhibits p62-dependent oxidative stress response (#226)

5:30 PM

Takashi Nozawa

Close evolutionary relationship between recent serotype M1 group A streptococcus isolates in Scotland and Iceland (#227)

5:30 PM

Randall J Olsen

Differential immune responses in Group A Streptococcal Necrotizing Soft Tissue infections. (#228)

5:30 PM

Laura Marcela Palma Medina

Complement factor H and susceptibility to rheumatic heart disease (#229)

5:30 PM

Tom Parks

Exploring the structural basis for CovR dysregulation in Australian M1_UK Group A Streptococcus   (#230)

5:30 PM

Jarrad Pritchard

The impact of glucose on motility and colorectal cancer cell invasion in Streptococcus gallolyticus subspecies gallolyticus and related species (#231)

5:30 PM

Adam Ralph

Group A streptococcal infection outcomes: clues from salivary sialic acid and comparative genomic analyses (#232)

5:30 PM

Chad Euler

Detection of the hypervirulent chimeric emm4 lineage in Australia (#233)

5:30 PM

Phoebe K Shaw

Streptococcus pyogenes is readily aerosolised but survives poorly on plastic: a comparison of 8 pathogenic species (#234)

5:30 PM

Christopher Smith

Group A Streptococcus and its virulent phage: playing ‘hide and seek’ in the human host (#235)

5:30 PM

Jenny M Steinmetz

The stabilization of streptolysin S secreted from β-hemolytic streptococci in the presence of human serum albumin. (#236)

5:30 PM

Atsushi Tabata

Investigating tropism of group A Streptococcus to epithelial and endothelial cells (#237)

5:30 PM

Vanessa Tenaglia

Exploring the immunological properties of Group A Streptococcus pilus (#238)

5:30 PM

Catherine Tsai

Multidrug resistance in group B streptococcus causing urinary tract infection exposes an erythromycin-driven protective effect against oxidative stress (#239)

5:30 PM

Glen Ulett

The sil system of Streptococcus anginosus: A key factor for survival in mixed cultures (#240)

5:30 PM

Verena Vogel

Pharmacokinetics of intramuscular benzathine penicillin G: a meta-analysis investigating time spent above target concentrations   (#241)

5:30 PM

Shakayla Walley

Construction of isogenic M1_UK mutants lacking scarlet fever-associated exotoxins    (#242)

5:30 PM

Jasmine Wells

Respiratory Group A Strep infections in stem cell models reveals divergent airway and alveolar epithelial cell responses (#243)

5:30 PM

Rhiannon Werder

GAS regulation of zinc homeostasis during skin and soft tissue infection (#244)

5:30 PM

Reid Wilkening

Mechanism of host-inflammatory response against Streptolysin S produced by Streptococcus anginosus via intracellular Ca²⁺-influx (#245)

5:30 PM

Yugo Yamamori

‘RHD in a dish’ -- Investigating the pathogenesis of Rheumatic Heart Disease using stem cell-derived heart valve organoids. (#246)

5:30 PM

Serene Yeow

Emerging role of biomarker-driven diagnostics in post-streptococcal glomerulonephritis (#247)

5:30 PM

Tawakaltu Abdulrasheed-Adeleke

A plasma protein biomarker signature that differentiates acute rheumatic fever from related clinical presentations (#248)

5:30 PM

Tim Barnett

The Immune Landscape of the Tonsils: A Critical Site for Understanding Group A Streptococcus Infections (#249)

5:30 PM

Anna Bergonzini

Systematic review and narrative synthesis of studies evaluating the characteristics of current Strep A molecular point-of-care tests towards implementation for Acute Rheumatic Fever (ARF) prevention. (#250)

5:30 PM

Asha Bowen

Analytical Evaluation of Three Commercially Available Molecular Point-of-Care Tests for Group A Streptococcus: A Harmonised Approach (#251)

5:30 PM

Asha Bowen

Improved detection of lymphocyte markers associated with rheumatic fever using engineered antibodies and multi-omics (#252)

5:30 PM

Chad Euler

Molecular diagnostics improve the detection of pathogenic streptococci causing complicated community-acquired pneumonia in children (#253)

5:30 PM

Erin C Ho

Investigating host-dependent antibiotic resistance in Streptococcus pyogenes (#254)

5:30 PM

Bonnie L Hyatt

Circulating prothymosin alpha and immunoglobulin G3 in acute rheumatic fever and rheumatic heart disease: A case control study (#255)

5:30 PM

Tom Parks

Antibody responses to conserved peptide sequences from the M-protein of group A streptococcus (#256)

5:30 PM

David J McMillan

Implementation of whole genome sequencing (WGS) replacing targeted emm gene sequencing in informing Group A Streptococcus pyogenes (GAS) outbreaks (#257)

5:30 PM

Kartyk Moganeradj

Development of a 10-plex electrochemiluminescent assay for quantifying specific serological immunoglobulin isotype and subclass responses to Streptococcus pyogenes antigens  (#258)

5:30 PM

Michael Morici

Identification of RNA Biomarkers for Acute Rheumatic Fever (ARF) (#259)

5:30 PM

Lara Oberski

Group A Streptococcus molecular point-of-care test performance in remote Australia (#260)

5:30 PM

Janessa Pickering

Detection of group B Streptococcus carriage among pregnant women by a cost-effective and faster approach based on MALDI-TOF MS (#261)

5:30 PM

Tatiana Pinto

Group A Streptococcus emm1/ST28: an emerging hipervirulent threat in Brazil (#262)

5:30 PM

André Rio Tinto

Development of a prototype for rapid point-of-care diagnosis of antibiotic-resistant Group A streptococcal and staphylococcal skin infections (#263)

5:30 PM

Kalindu Rodrigo

Diagnostic accuracy of the 2023 world heart federation screening criteria for rheumatic heart disease in a high-risk population (#264)

5:30 PM

Joselyn Rwebembera

Long-term persistence of Group A Streptococcal antibodies in a Rheumatic heart disease African cohort : A pilot study (#265)

5:30 PM

Taariq Salie

Comparative analysis of Strep A bacterial detection methods in an Australian paediatric urban pharyngitis surveillance study   (#266)

5:30 PM

Anna Takahashi

Possibility of developing a biomarker based rapid screening test for ARF/RHD (#268)

5:30 PM

Brenda Vo

Surveillance of Streptococus pyogenes induced pharyngitis in children from refugee and asylum seeker backgrounds via collaboration with a local health service (#269)

5:30 PM

Ciara Baker

Moorditj marp (strong skin): strengthening skin health outcomes through community driven research and translation initiatives (#270)

5:30 PM

Asha Bowen

Taking an environmental health approach to preventing Strep A infections and Acute Rheumatic Fever (#271)

5:30 PM

Asha Bowen

Significance of community engagement strategies for group a streptococcus surveillance. researchers’ experience from a pacific island context (#272)

5:30 PM

Roneel RC Chandra

Subcutaneous injections of penicillin: Convenient and effective treatment for Māori, Pacific Peoples and their whānau in preventing rheumatic heart disease (#273)

5:30 PM

Julie Cooper

Household transmission of Streptococcus pyogenes (Strep A): a review to inform potential environmental health interventions for remote living Aboriginal communities at high risk of rheumatic fever (#274)

5:30 PM

Stephanie Enkel

The human side of RHD: connecting personal stories to scientific solutions (#275)

5:30 PM

Anu Gomanju

Addressing rheumatic heart disease in the Pacific (#276)

5:30 PM

Joseph H Kado

Rapua te mea ngaro ka tau: culturally responsive governance applied to vaccine development (#277)

5:30 PM

Shannon Leilua

Identifying environmental risk factors for acute rheumatic fever (arf) (#278)

5:30 PM

Ela Monteiro

Cultural safety training for new zealand secondary prophylaxis providers for rheumatic fever (#279)

5:30 PM

Monleigh MM Muliaumasealii

Whitia kia ora indigenous health care model for rheumatic fever (#280)

5:30 PM

Monleigh MM Muliaumasealii

Determining the impact of acute rheumatic fever on children's quality of life (#281)

5:30 PM

Emma Ndagire

Parent Led Sample Collection: An Innovative Method for Enhancing Participant Recruitment in a Research Surveillance Study During a Pandemic (#282)

5:30 PM

Elizabeth Negus

Communication Strategies Used to Maximise Community-Based Participation in the Sore Throat Study in Perth and Melbourne (#283)

5:30 PM

Elizabeth Negus

The experience of streptococcal pharyngitis human challenge trial participants (#284)

5:30 PM

Jane Oliver

Gaining community insight into Group A streptococcus isolate research and care (#285)

5:30 PM

Tira TPP Phillipson-puna

The Wash Up – Understanding Specifications for Washing Clothes and Bedding to Reduce Skin Infections: An Integrated Approach (#286)

5:30 PM

Kate Summer

Transmission of Strep A via Fabric Fomites and the Role of Laundering: Knowns and Unknowns (#287)

5:30 PM

Kate Summer

Check4Strep a community-based pilot project to understand and respond to infection with Group A Streptococcus (#288)

5:30 PM

Vicki Wade

Infectious diseases associated with inadequate housing and Healthy Living Practice capacity in Australia: a systematic review (#289)

5:30 PM

Rosemary Wyber

Human antibodies to M-protein epitope-based vaccines demonstrate binding to Streptococcus pyogenes (StrepA) and bactericidal activity (#290)

5:30 PM

Christie T M Short

Models of Vaccine Finance with an Application to Potential Group A Strep Vaccines (#291)

5:30 PM

Daniel Tortorice

Molecular dissection of Streptococcus suis surface glycans reveals conserved glycan motifs with implications in vaccine development (#292)

5:30 PM

Nina M. van Sorge

Delineating Humoral and Cellular Immune Responses Induced by a Peptide-Based Vaccine for Protection Against Streptococcus pyogenes (#293)

5:30 PM

Despena Vedis

Protective properties of Enn surface proteins against Group A Streptococcus. (#294)

5:30 PM

Cyprien Widomski

Streptococcus pyogenes evades antibody recognition through decoration of the Group A Lancefield antigen with glycerol phosphate (#295)

5:30 PM

Astrid Hendriks

Pericardial Effusion in Acute Rheumatic Fever and Rheumatic Heart Disease (#296)

5:30 PM

Masood Sadiq